India, Sept. 14 -- CDMO (Contract Development and Manufacturing Organisation) refers to a company that provides drug development and manufacturing services to pharmaceutical companies. CDMOs can support the entire process, from developing and optimising a drug or API to clinical-stage manufacturing and commercial-scale production, allowing pharma companies to outsource these activities.

The estimated value of the India CDMO Market is USD 8.52 billion in 2025, which is forecasted to reach USD 16.53 billion by 2034, with a growth rate of 7.39% for the period 2026-2034.

The growth drivers include cost-efficient production processes, vast scientific workforce availability, government support like the PLI scheme, and diversification of th...